| Dr Jessica Lynn Donner, MD | |
|
1445 North Ave, Spearfish, SD 57783-1552 | |
| (605) 644-4170 | |
| (604) 644-4198 |
| Full Name | Dr Jessica Lynn Donner |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 1445 North Ave, Spearfish, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215137179 | NPI | - | NPPES |
| 24788767 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 50130 (Colorado) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 9276 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Spearfish Hospital | Spearfish, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monument Health Network Inc | 5991616427 | 143 |
News Archive
In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study - a 10-nation, randomized clinical trial of adult outpatients - investigators concluded that there was no added benefit of using four drugs for TB over just using one drug, isoniazid, to save lives in people with advanced HIV/AIDS.
The Frank May Prize Lecture 2010 will be given by Dr Russell Wallis, speaking on microbial pathogens, and will be on Wednesday 1st December 2010, 5.30pm, in the Frank and Katherine May Lecture Theatre, Henry Wellcome Building (Lancaster Road), University of Leicester.
By cloaking nanoparticles in the membranes of white blood cells, scientists at The Methodist Hospital Research Institute may have found a way to prevent the body from recognizing and destroying them before they deliver their drug payloads. The group describes its "LeukoLike Vectors", or LLVs, in the January issue of Nature Nanotechnology.
Cardinal Health today announced an agreement to acquire privately held AccessClosure Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, for $320 million. Subject to customary closing conditions and regulatory clearances, the all-cash transaction is expected to close by early June 2014.
› Verified 2 days ago
| Entity Name | Monument Health Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588185268 PECOS PAC ID: 5991616427 Enrollment ID: O20031111000854 |
News Archive
In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study - a 10-nation, randomized clinical trial of adult outpatients - investigators concluded that there was no added benefit of using four drugs for TB over just using one drug, isoniazid, to save lives in people with advanced HIV/AIDS.
The Frank May Prize Lecture 2010 will be given by Dr Russell Wallis, speaking on microbial pathogens, and will be on Wednesday 1st December 2010, 5.30pm, in the Frank and Katherine May Lecture Theatre, Henry Wellcome Building (Lancaster Road), University of Leicester.
By cloaking nanoparticles in the membranes of white blood cells, scientists at The Methodist Hospital Research Institute may have found a way to prevent the body from recognizing and destroying them before they deliver their drug payloads. The group describes its "LeukoLike Vectors", or LLVs, in the January issue of Nature Nanotechnology.
Cardinal Health today announced an agreement to acquire privately held AccessClosure Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, for $320 million. Subject to customary closing conditions and regulatory clearances, the all-cash transaction is expected to close by early June 2014.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Lynn Donner, MD 353 Fairmont Blvd, Atten Christie Mss, Rapid City, SD 57701-7350 Ph: (303) 690-2198 | Dr Jessica Lynn Donner, MD 1445 North Ave, Spearfish, SD 57783-1552 Ph: (605) 644-4170 |
News Archive
In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study - a 10-nation, randomized clinical trial of adult outpatients - investigators concluded that there was no added benefit of using four drugs for TB over just using one drug, isoniazid, to save lives in people with advanced HIV/AIDS.
The Frank May Prize Lecture 2010 will be given by Dr Russell Wallis, speaking on microbial pathogens, and will be on Wednesday 1st December 2010, 5.30pm, in the Frank and Katherine May Lecture Theatre, Henry Wellcome Building (Lancaster Road), University of Leicester.
By cloaking nanoparticles in the membranes of white blood cells, scientists at The Methodist Hospital Research Institute may have found a way to prevent the body from recognizing and destroying them before they deliver their drug payloads. The group describes its "LeukoLike Vectors", or LLVs, in the January issue of Nature Nanotechnology.
Cardinal Health today announced an agreement to acquire privately held AccessClosure Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, for $320 million. Subject to customary closing conditions and regulatory clearances, the all-cash transaction is expected to close by early June 2014.
› Verified 2 days ago
Heather A Brewer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1445 North Ave, Spearfish, SD 57783 Phone: 605-644-4170 Fax: 605-644-4198 |